Screener
AnaptysBio, Inc. ANAB Royalty Management Company — Operating Expenses
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
| Line item | Biopharma | Royalty Management | Total |
|---|---|---|---|
| External G&A(3) | 8,721 | 3,398 | 12,119 |
| Internal G&A(2) | 10,135 | 3,948 | 14,083 |
| Total G&A | 18,856 | 7,346 | 26,202 |
| Total operating expenses | 52,811 | 7,382 | 60,193 |
| (Loss) income from operations | (52,811) | 18,174 | (34,637) |
| Interest income | 2,328 | 325 | 2,653 |
| Non-cash interest expense | — | (20,859) | (20,859) |
| Other expense, net | (1) | — | (1) |
Item 1. Consolidated Financial Statements
FAQ
- What is AnaptysBio, Inc.'s royalty management company — operating expenses?
- AnaptysBio, Inc. (ANAB) reported royalty management company — operating expenses of $7.38M in Q1 2026.
- How has AnaptysBio, Inc.'s royalty management company — operating expenses changed year-over-year?
- AnaptysBio, Inc.'s royalty management company — operating expenses increased by 83.2% year-over-year, from $4.03M to $7.38M.
- What does royalty management company — operating expenses mean?
- This metric aggregates all costs incurred to operate the royalty management segment, including research, development, and administrative overhead. It provides a comprehensive view of the total resource consumption required to sustain the segment's business activities.
Ask your AI about AnaptysBio, Inc.'s royalty management company — operating expenses.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude